Proposed changes to the Association of the British Pharmaceutical Industry code of practice, now out for consultation, could help improve transparency in the pharmaceutical industry1. But plans to limit branded giveaways to healthcare professionals could disproportionately hurt smaller firms, making the code "unfit for purpose", warns the Ethical Medicines Industry Group, EMIG2...
Please login to read the full article.
